Spatially Resolved Transcriptomics: Revealing Tumor Microenvironment Heterogeneity to Advance Cancer Immunotherapy
Small Methods · 2025-11 · 9 (11)
DOI: 10.1002/smtd.202500770 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small Methods, online erschienen am 04.09.2025. Verfasst von Dan Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Research Centre of Molecular Medicine of Ministry of Education Key Laboratory of Fujian Molecular Medicine School of Medicine, Huaqiao Un…. Hauptthemen laut MEDLINE: Tumor Microenvironment, Immunotherapy, Neoplasms, Transcriptome. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 135 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Scientific Research Foundation of the State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory.
Abstract (Originalsprache)
Despite the availability of numerous approved immunotherapies for various cancers, durable progression‐free survival remains relatively uncommon among patients with advanced cancer. As research into immunotherapy intensifies, the heterogeneity and complexity of the tumor microenvironment (TME) have emerged as critical determinants of treatment response and a major obstacle to understanding tumor resistance mechanisms. Recent advances in spatially resolved transcriptomics (SRT) enable transcriptome‐wide measurement of gene expression while preserving essential spatial information, which supports the characterization of the features of the TME. This review outlines key challenges in cancer immunotherapy and emphasizes the importance of the TME in determining therapeutic efficacy. SRT strategies suitable is systematically introduced for TME profiling, comparing their relative advantages and limitations. Additionally, bioinformatics tools and methods used to reconstruct spatial tissue patterns are discussed from SRT data. Furthermore, how SRT is explored can enhance the understanding of the complexity and heterogeneity of the TME, facilitate the identification of novel therapeutic targets, and advance biomarker discovery to refine personalized treatment strategies for diverse cancer patients. Finally, future perspectives on the application of SRT in cancer immunotherapy and addressing the associated challenges are provided.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Engineering Research Centre of Molecular Medicine of Ministry of Education Key Laboratory of Fujian Molecular Medicine School of Medicine, Huaqiao University, Xiamen, 361021, China.
- The MOE Key Laboratory of Spectrochemical Analysis & Instrumentation the Key Laboratory of Chemical Biology of Fujian Province State Key Laboratory of Physical Chemistry of Solid Surfaces Collaborative Innovation Center…
ORCID-Profile: Dan Liu, Chaoyong Yang
Förderung
- National Natural Science Foundation of China
- Scientific Research Foundation of the State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory
Zitieren
APA
Liu, D., Xiao, L., Wu, Y., Yue, C., Li, M., Sun, Y., & Yang, C. (2025). Spatially Resolved Transcriptomics: Revealing Tumor Microenvironment Heterogeneity to Advance Cancer Immunotherapy. Small Methods, 9(11). https://doi.org/10.1002/smtd.202500770
Vancouver
Liu D, Xiao L, Wu Y, Yue C, Li M, Sun Y, et al. Spatially Resolved Transcriptomics: Revealing Tumor Microenvironment Heterogeneity to Advance Cancer Immunotherapy. Small Methods. 2025;9(11). doi:10.1002/smtd.202500770
BibTeX
@article{Liu2025,
author = {Liu, Dan and Xiao, Lu and Wu, Yuyuan and Yue, Chensirong and Li, Mengmeng and Sun, Yuanpei and Yang, Chaoyong},
title = {Spatially Resolved Transcriptomics: Revealing Tumor Microenvironment Heterogeneity to Advance Cancer Immunotherapy},
journal = {Small Methods},
year = {2025},
volume = {9},
number = {11},
doi = {10.1002/smtd.202500770}
}
EUVIMED